| 000 | 01642 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516122335.0 | ||
| 264 | 0 | _c20130503 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1660-3397 | ||
| 024 | 7 |
_a10.3390/md10102166 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSzymanski, Pawel T | |
| 245 | 0 | 0 |
_aSarcophine-diol inhibits expression of COX-2, inhibits activity of cPLA2, enhances degradation of PLA2 and PLC(γ)1 and inhibits cell membrane permeability in mouse melanoma B16F10 cells. _h[electronic resource] |
| 260 |
_bMarine drugs _cOct 2012 |
||
| 300 |
_a2166-2180 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnthozoa _xchemistry |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Membrane Permeability _xdrug effects |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xgenetics |
| 650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aDiterpenes _xchemistry |
| 650 | 0 | 4 | _aGene Expression Regulation, Enzymologic |
| 650 | 0 | 4 |
_aMelanoma _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPhospholipase C gamma _xgenetics |
| 650 | 0 | 4 |
_aPhospholipases A2, Cytosolic _xantagonists & inhibitors |
| 700 | 1 | _aMuley, Pratik | |
| 700 | 1 | _aAhmed, Safwat A | |
| 700 | 1 | _aKhalifa, Sherief | |
| 700 | 1 | _aFahmy, Hesham | |
| 773 | 0 |
_tMarine drugs _gvol. 10 _gno. 10 _gp. 2166-2180 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/md10102166 _zAvailable from publisher's website |
| 999 |
_c22281330 _d22281330 |
||